FDA says J&J single-dose shot prevents Covid; final decision soon
Johnson & Johnson's single-dose vaccine protects against Covid-19, according to an analysis by U.S. regulators Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.
The Food and Drug Administration's scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe Covid-19.
Read more...